New molecular targets for the treatment of sarcoidosis. - Wikidata - awgldk - TriplyDB

New molecular targets for the treatment of sarcoidosis.

New molecular targets for the treatment of sarcoidosis.

http://www.wikidata.org/entity/Q37494750

about

Transcriptional Survey of Alveolar Macrophages in a Murine Model of Chronic Granulomatous Inflammation Reveals Common Themes with Human Sarcoidosis.

P2860

Q50046060-1D8B0FAF-5C20-449F-BB82-D7372A53361E

P2860

New molecular targets for the treatment of sarcoidosis.

http://www.wikidata.org/entity/Q37494750

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New molecular targets for the treatment of sarcoidosis.

@en

New molecular targets for the treatment of sarcoidosis.

@nl

type

label

New molecular targets for the treatment of sarcoidosis.

@en

New molecular targets for the treatment of sarcoidosis.

@nl

prefLabel

New molecular targets for the treatment of sarcoidosis.

@en

New molecular targets for the treatment of sarcoidosis.

@nl

P1433

Q37494750-3D30D613-D06B-4948-9E40-3686DE152524

P1476

Q37494750-F9B1DBED-2236-4B6A-8C2A-97900465B9E7

P2093

Q37494750-0A6727CD-25F3-4F1D-A926-4B19AC0353B7

Q37494750-6AE9E67E-2581-4814-B126-46D4AD112F81

Q37494750-B0EAE640-517D-4A8E-A3EB-1239594011B0

P2860

Q37494750-00F2C5F3-AA74-4A34-9D7B-591D39FF71C8

Q37494750-052917C7-DE55-466F-84AE-440A3BE22389

Q37494750-16144D76-B9FC-4159-BCAA-FF5EFFB2E378

Q37494750-1A487BC5-610A-4399-A263-7FEFA5B8F4F6

Q37494750-1C79A83C-F372-43C7-B634-D332A43AB66C

Q37494750-1E62F38D-C0EB-4BC9-994F-227C1E2C902B

Q37494750-1FE2B6CF-B76B-430D-AD32-38D847576120

Q37494750-205CB374-88FF-4372-9E83-F78AF5BCCB06

Q37494750-29433642-8B9B-4913-8F5B-EEFE42B424C4

Q37494750-2A4972F1-FA85-4CB7-8A8D-F0B5EE298202

P304

Q37494750-CB6972DB-E044-4106-8DF8-7ABF021BB54B

P31

Q37494750-35F9AB6F-45F3-464F-88DD-691D4B45D1F8

P356

Q37494750-BA4337EE-D978-4892-A8D3-FCE3B345C981

P433

Q37494750-61C346B2-C4F3-4AA9-A32C-0326DE469112

P478

Q37494750-B5799F56-0DBE-4BE7-BE09-1F812534062C

P577

Q37494750-DABD2308-29C2-4415-BD38-96E1D563A715

P698

Q37494750-B16773DC-D068-4DDB-AAB7-980FE744C2B2

P932

Q37494750-5068DF45-13AF-45F2-A5CD-ECA273B0F791

P356

MCP.0000000000000304

P1433

Current Opinion in Pulmonary Medicine

P1476

New molecular targets for the treatment of sarcoidosis.

@en

P2093

Bill B Chen

http://www.w3.org/2001/XMLSchema#string

Jared Chiarchiaro

http://www.w3.org/2001/XMLSchema#string

Kevin F Gibson

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis

NLRP3 inflammasome and its inhibitors: a review

Leflunomide: a drug with a potential beyond rheumatology

Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease.

Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells.

British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.

Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.

Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis

Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.

Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis

P304

515-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MCP.0000000000000304

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27454074

http://www.w3.org/2001/XMLSchema#string

P932

5152532

http://www.w3.org/2001/XMLSchema#string